SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hui Zhang, Faya Zhang, Zhaohui Zhu, Dung Luong, Gary G. Meadows, Chronic alcohol consumption enhances iNKT cell maturation and activation, Toxicology and Applied Pharmacology, 2015, 282, 2, 139

    CrossRef

  2. 2
    Igor Maricic, Huiming Sheng, Idania Marrero, Ekihiro Seki, Tatiana Kisseleva, Som Chaturvedi, Natasha Molle, Stephanie A. Mathews, Bin Gao, Vipin Kumar, Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice, Hepatology, 2015, 61, 4
  3. 3
    Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao, The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis, Journal of Clinical and Experimental Hepatology, 2015,

    CrossRef

  4. You have free access to this content4
    Zili Zhang, Feng Zhang, Yin Lu, Shizhong Zheng, Update on implications and mechanisms of angiogenesis in liver fibrosis, Hepatology Research, 2015, 45, 2
  5. 5
    Tim Dalessandri, Jessica Strid, Beneficial Autoimmunity at Body Surfaces – Immune Surveillance and Rapid Type 2 Immunity Regulate Tissue Homeostasis and Cancer, Frontiers in Immunology, 2014, 5,

    CrossRef

  6. 6
    Sandra M. Blois, Flavia Piccioni, Nancy Freitag, Irene Tirado-González, Petra Moschansky, Rodrigo Lloyd, Karin Hensel-Wiegel, Matthias Rose, Mariana G. Garcia, Laura D. Alaniz, Guillermo Mazzolini, Dendritic cells regulate angiogenesis associated with liver fibrogenesis, Angiogenesis, 2014, 17, 1, 119

    CrossRef

  7. 7
    Abhisek Mitra, Arun Satelli, Jun Yan, Xia Xueqing, Mihai Gagea, Christopher A. Hunter, Lopa Mishra, Shulin Li, IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice, Hepatology, 2014, 60, 6
  8. 8
    Elena Rigamonti, Paola Zordan, Clara Sciorati, Patrizia Rovere-Querini, Silvia Brunelli, Macrophage Plasticity in Skeletal Muscle Repair, BioMed Research International, 2014, 2014, 1

    CrossRef

  9. 9
    Juanjuan Zhao, Zheng Zhang, Yan Luan, Zhengsheng Zou, Yanling Sun, Yonggang Li, Lei Jin, Chunbao Zhou, Junliang Fu, Bin Gao, Yangxin Fu, Fu-Sheng Wang, Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment, Hepatology, 2014, 59, 4
  10. 10
    Stefan W. Ryter, Augustine M.K. Choi, Hong Pyo Kim, Profibrogenic phenotype in caveolin-1 deficiency via differential regulation of STAT-1/3 proteins, Biochemistry and Cell Biology, 2014, 92, 5, 370

    CrossRef

  11. 11
    Johnny Amer, Rami Grifat, Sarit Doron, Lina Abu-Tair, Rufayda Mruwat, Areej El-Khatib, Rifaat Safadi, The pro-fibrotic effects of pregnancy in a carbon-tetrachloride-induced liver injury in mouse model, Liver International, 2014, 34, 8
  12. 12
    Hisafumi Yamagata, Kenichi Ikejima, Kazuyoshi Takeda, Tomonori Aoyama, Kazuyoshi Kon, Ko Okumura, Sumio Watanabe, Altered expression and function of hepatic natural killer T cells in obese and diabetic KK-Ay mice, Hepatology Research, 2013, 43, 3
  13. 13
    Desong Kong, Feng Zhang, Zili Zhang, Yin Lu, Shizhong Zheng, Clearance of activated stellate cells for hepatic fibrosis regression: Molecular basis and translational potential, Biomedicine & Pharmacotherapy, 2013, 67, 3, 246

    CrossRef

  14. 14
    Detlef Schuppan, Yong Ook Kim, Evolving therapies for liver fibrosis, Journal of Clinical Investigation, 2013, 123, 5, 1887

    CrossRef

  15. 15
    A Sagiv, A Biran, M Yon, J Simon, S W Lowe, V Krizhanovsky, Granule exocytosis mediates immune surveillance of senescent cells, Oncogene, 2013, 32, 15, 1971

    CrossRef

  16. 16
    Yizhong Wang, Jieliang Li, Xu Wang, Min Sang, Wenzhe Ho, Hepatic stellate cells, liver innate immunity, and hepatitis C virus, Journal of Gastroenterology and Hepatology, 2013, 28,
  17. 17
    Laura Senovilla, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Immunosurveillance as a regulator of tissue homeostasis, Trends in Immunology, 2013, 34, 10, 471

    CrossRef

  18. 18
    Yun-Chang Koo, Chung-Oui Hong, Mi-Hyun Nam, Ji Hoon Kim, Sung-Yong Yang, Nam-Hee Won, Tae-Sun Park, Kwang-Won Lee, Inhibitory effect of yellow myrobalan (Terminalia chebula) extract on fibrosis induced by carbon tetrachloride in rat liver, Food Science and Biotechnology, 2013, 22, 3, 871

    CrossRef

  19. 19
    Hyon-Seung Yi, Won-Il Jeong, Interaction of hepatic stellate cells with diverse types of immune cells: Foe or friend?, Journal of Gastroenterology and Hepatology, 2013, 28,
  20. 20
    Hua Wang, Dechun Feng, Ogyi Park, Shi Yin, Bin Gao, Invariant NKT cell activation induces neutrophil accumulation and hepatitis: Opposite regulation by IL-4 and IFN-γ, Hepatology, 2013, 58, 4
  21. 21
    Joy X. Jiang, Natalie J. Török, Liver Injury and the Activation of the Hepatic Myofibroblasts, Current Pathobiology Reports, 2013, 1, 3, 215

    CrossRef

  22. 22
    Evaggelia Liaskou, Henning W. Zimmermann, Ka-Kit Li, Ye H. Oo, Shankar Suresh, Zania Stamataki, Omar Qureshi, Patricia F. Lalor, Jean Shaw, Wing-kin Syn, Stuart M. Curbishley, David H. Adams, Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics, Hepatology, 2013, 57, 1
  23. 23
    Bin Gao, Svetlana Radaeva, Natural killer and natural killer T cells in liver fibrosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 7, 1061

    CrossRef

  24. 24
    Jochen Mattner, Natural killer T (NKT) cells in autoimmune hepatitis, Current Opinion in Immunology, 2013, 25, 6, 697

    CrossRef

  25. 25
    Marina Berenguer, Detlef Schuppan, Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment, Journal of Hepatology, 2013, 58, 5, 1028

    CrossRef

  26. You have free access to this content26
    Yasuhiro Miyake, Kazuhide Yamamoto, Role of gut microbiota in liver diseases, Hepatology Research, 2013, 43, 2
  27. 27
    S. Zhu, H. Zhang, Y. Dong, Z. Xu, D. Chen, L. Wang, Y. Gan, F. Wang, Y. Wang, X. Xing, S. Hu, Z. Li, L. Long, L. Liu, Y. Zhong, The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B, Clinical & Experimental Immunology, 2013, 171, 3
  28. 28
    Miroslaw Kornek, Michael Lynch, Shruti H. Mehta, Michelle Lai, Mark Exley, Nezam H. Afdhal, Detlef Schuppan, Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis, Gastroenterology, 2012, 143, 2, 448

    CrossRef

  29. 29
    Jingjing Jiao, David Sastre, Maria Isabel Fiel, Ursula E. Lee, Zahra Ghiassi-Nejad, Florent Ginhoux, Eric Vivier, Scott L. Friedman, Miriam Merad, Costica Aloman, Dendritic cell regulation of carbon tetrachloride–induced murine liver fibrosis regression, Hepatology, 2012, 55, 1
  30. 30
    David Y. Zhang, Scott L. Friedman, Fibrosis-dependent mechanisms of hepatocarcinogenesis, Hepatology, 2012, 56, 2
  31. 31
    Hajime Tanaka, Patrick S. C. Leung, Tom P. Kenny, M. Eric Gershwin, Christopher L. Bowlus, Immunological Orchestration of Liver Fibrosis, Clinical Reviews in Allergy & Immunology, 2012, 43, 3, 220

    CrossRef

  32. 32
    H. Q. Sun, J. Y. Zhang, H. Zhang, Z. S. Zou, F. S. Wang, J. H. Jia, Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis, Journal of Viral Hepatitis, 2012, 19, 6
  33. 33
    Y. Liu, X. Luan, J. Li, Y. He, M. Li, The Role of Invariant NKT Cells in Liver Transplant Tolerance in Rats, Transplantation Proceedings, 2012, 44, 4, 1041

    CrossRef

  34. 34
    Savita Bisht, Mehtab A Khan, Mena Bekhit, Haibo Bai, Toby Cornish, Masamichi Mizuma, Michelle A Rudek, Ming Zhao, Amarnath Maitra, Balmiki Ray, Debomoy Lahiri, Anirban Maitra, Robert A Anders, A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation, Laboratory Investigation, 2011, 91, 9, 1383

    CrossRef

  35. 35
    Zixue Jin, Rui Sun, Haiming Wei, Xiang Gao, Yongyan Chen, Zhigang Tian, Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells, Hepatology, 2011, 53, 1
  36. 36
    Sachiko Ishikawa, Kenichi Ikejima, Hisafumi Yamagata, Tomonori Aoyama, Kazuyoshi Kon, Kumiko Arai, Kazuyoshi Takeda, Sumio Watanabe, CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice, Journal of Hepatology, 2011, 54, 6, 1195

    CrossRef

  37. 37
    Uzma Kanwal, Cyphostemma glaucophilla May Serve as a Cheap Protectant of Liver and Kidney, Pakistan Journal of Biological Sciences, 2011, 14, 19, 912

    CrossRef

  38. 38
    Si-Jie Wu, Yao-Hsu Yang, Koichi Tsuneyama, Patrick S.C. Leung, Petr Illarionov, M. Eric Gershwin, Ya-Hui Chuang, Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis , Hepatology, 2011, 53, 3
  39. 39
    Hua Wang, Ogyi Park, Bin Gao, NKT cells in liver fibrosis: Controversies or complexities, Journal of Hepatology, 2011, 55, 5, 1166

    CrossRef

  40. 40
    Virginia Hernandez-Gea, Scott L. Friedman, Pathogenesis of Liver Fibrosis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 425

    CrossRef

  41. 41
    Kenichi Ikejima, Sachiko Ishikawa, Sumio Watanabe, Reply to: “NKT cells in liver fibrosis: Controversies or complexities”, Journal of Hepatology, 2011, 55, 5, 1166

    CrossRef

  42. 42
    Caroline C Duwaerts, Stephen H Gregory, Targeting the diverse immunological functions expressed by hepatic NKT cells, Expert Opinion on Therapeutic Targets, 2011, 15, 8, 973

    CrossRef

  43. 43
    HanYong Sun, Lei Chen, WeiPing Zhou, Liang Hu, Liang Li, QianQian Tu, YanXin Chang, Qu Liu, XueJun Sun, MengChao Wu, HongYang Wang, The protective role of hydrogen-rich saline in experimental liver injury in mice, Journal of Hepatology, 2011, 54, 3, 471

    CrossRef

  44. 44
    Wing-Kin Syn, Ye Htun Oo, Thiago A. Pereira, Gamze F. Karaca, Youngmi Jung, Alessia Omenetti, Rafal P. Witek, Steve S. Choi, Cynthia D. Guy, Caitlin M. Fearing, Vanessa Teaberry, Fausto E.L. Pereira, David H. Adams, Anna Mae Diehl, Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease, Hepatology, 2010, 51, 6
  45. 45
    Scott L. Friedman, Evolving challenges in hepatic fibrosis, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 8, 425

    CrossRef

  46. 46
    Jin-Seok Byun, Won-Il Jeong, Involvement of Hepatic Innate Immunity in Alcoholic Liver Disease, Immune Network, 2010, 10, 6, 181

    CrossRef

  47. 47
    Massimo Pinzani, Jose Macias-Barragan, Update on the pathophysiology of liver fibrosis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 459

    CrossRef

  48. 48
    Fabio Marra, Sara Aleffi, Sara Galastri, Angela Provenzano, Mononuclear cells in liver fibrosis, Seminars in Immunopathology, 2009, 31, 3, 345

    CrossRef

  49. 49
    Nicolas Lanthier, Yves Horsmans, Isabelle A Leclercq, The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis, Current Opinion in Clinical Nutrition and Metabolic Care, 2009, 12, 4, 404

    CrossRef